Carsten Thiel, EVP of Alexion Pharmaceuticals, recently disposed of 3,000 shares of the company. The disposals took place at $173.34 per share, on November 10, 2015. Thiel still owns 28,018 shares of the company. Thiel operates out of Cheshire, CT. Some additional info was provided as follows:
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $173.20 - $174.19. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever Alexion Pharmaceuticals makes a similar move, sign up!
Other recent filings from the company include the following:
T. ROWE PRICE ASSOCIATES, INC. just provided an update on share ownership of Alexion Pharmaceuticals - Feb. 14, 2018
STATE STREET CORPORATION just provided an update on share ownership of Alexion Pharmaceuticals - Feb. 13, 2018
The Vanguard Group just provided an update on share ownership of Alexion Pharmaceuticals - Feb. 12, 2018
SVP of Alexion Pharmaceuticals just picked up 17,203 shares - Feb. 8, 2018
Alexion Pharmaceuticals's EVP & Chief Commercial Officer just picked up 14,243 shares - Feb. 8, 2018